Drug intelligence / Profile preview

Tongluo Mingmu

Development stage
Unknown
Lead developer
Yiling Pharmaceutical
Administration
Oral
01

Overview

Tongluo Mingmu is a Traditional Chinese Medicine (TCM) formulation, typically administered as oral granules or capsules, specifically developed for the treatment of retinal vascular disorders such as non-proliferative diabetic retinopathy (NPDR). The formulation is designed according to TCM principles to "unblock collaterals" (Tongluo) and "improve eyesight" (Mingmu), primarily by enhancing retinal microcirculation, reducing vascular permeability, and providing neuroprotective effects to the retina. In clinical practice and research, such as trials sponsored by the First Hospital of Northwest University, it is frequently evaluated as an adjunctive therapy alongside Western vasoprotective agents like calcium dobesilate to optimize fundus recovery and visual acuity in diabetic patients.

Brand names
Tongluo Mingmu
Other names
Tongluo Mingmu GranulesTongluo Mingmu CapsulesTongluo Mingmu Keli

Beyond the preview

Go deeper on Tongluo Mingmu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongluo Mingmu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call